US biotech firm Moderna said Sunday that American officials have delayed approving its COVID-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis,...
from NDTV News - Special https://ift.tt/3CzxYlY
via
No comments:
Post a Comment